• Supreme Cannabis completes landmark international medical cannabis export from Canada to Israel 
  • Supreme Cannabis’ international medical brand, Truverra, to be sold through BOL Pharma’s network of pharmacies across Israel 
  • Supreme Cannabis provides update on corporate activities amid the COVID-19 pandemic 

TORONTO, April 2, 2020 /CNW/ – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced the completion of its first international cannabis shipment from Canada into Israel. Supreme Cannabis partnered with Breath of Life International Ltd. (“BOL Pharma”), Israel’s largest and leading producer of medical cannabis and cannabis products, to offer Truverra-branded premium medical cannabis to patients in Israel.

Supreme Cannabis

Colin Moore, Interim President and CEO of Supreme Cannabis said:

“This transaction represents a new international revenue opportunity for Supreme Cannabis and builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world. With the support of BOL Pharma, we navigated both Canada and Israel’s complex regulatory landscapes to achieve compliance with regulatory authorities in both countries, including Health Canada, the Canadian Food Inspection Agency and Israel’s Ministry of Health and Ministry of Agriculture and Rural Development. We benefitted from BOL Pharma’s skilled team, international experience and solidified the position as a leading medical cannabis company in Israel. As we pursue capital-light international opportunities, we will continue to look to Jeff Adams, Truverra’s CEO, and his exceptional team to build Truverra’s medical brand globally.”  

Dr. Tamir Gedo, CEO of BOL Pharma said:

“We are pleased to address the growing demand for premium indoor grown medical cannabis products in Israel through our first cannabis import from Canada. Supreme Cannabis is a partner that shares our high standards for quality and respect for patients and consumers. On March 30, Truverra products became available across pharmacies in Israel and we are already receiving positive feedback from patients. We look forward to continuing to work with Supreme Cannabis and to offering Truverra’s premium medical cannabis to patients in Israel.”

BOL Pharma has been involved in researching and developing cannabis-based products for 13 years.

It is the largest medical cannabis company in Israel and the only one to handle all stages of cultivation and production, ensuring compliance with the strictest standards set by the Israeli Ministry of Health and EU-GMP conditions. BOL Pharma is distributing Truverra’s medical cannabis in 10-gram containers to its network of pharmacies across Israel. 

Truverra’s cannabis was grown at Supreme Cannabis’ 440,000 square foot premium indoor hybrid cultivation facility (the “7ACRES Facility”) in Kincardine, Ontario. The Truverra branded medical cannabis was purposefully grown and allocated to this international medical opportunity. Supreme Cannabis continues to operate internationally in the EU and UK through Truverra’s CBD e-commerce business (truverra.com).

COVID-19 Corporate Update 

 “As an essential business in Ontario and other Canadian provinces, Supreme Cannabis has the privilege to continue to produce products for our consumers, to provide income opportunities to our employees and to continue to support the communities we operate in,” said Colin Moore. 

Supreme Cannabis continues to work to mitigate risk and manage disruption to its operations. With the implementation of remote work when possible and increased precautionary measures at its facilities, including:

  • Limited shift sizes
  • The separation between shifts
  • Additional sterilization processes
  • Staggered breaks
  • And continued access to personal protective equipment such as gloves and masks. 

These health, safety and sanitation measures have been applied in addition to the Company’s usual best-practices.

Supreme Cannabis has also experienced some minor external business disruptions due to the COVID-19 pandemic, including supplier and third-party testing delays. These delays have pushed out the launch dates for 7ACRES’ whole flower pre-rolls and PAX pods for the PAX Era vaporizer. These new products were originally slated to be introduced to the Canadian market in the Company’s fiscal Q3, ending March 31, 2020 and are now expected to be available in fiscal Q4. 

The Company’s top priority continues to be the well-being of its employees.

Supreme Cannabis is pleased to announce that current front-line employees are receiving temporary recognition pay in acknowledgement of their hard work through these difficult times. At the same time, Supreme Cannabis remains committed to making a positive impact in the communities it operates in. This past week, employees at the 7ACRES Facility led an initiative to donate 500 N95 masks to Bruce County first responders. The Company continues to look for opportunities to support its local communities through these challenging conditions. 

About Supreme Cannabis. 

The Supreme Cannabis Company, Inc., (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the Company has emerged as one of the world’s fastest-growing, premium plant-driven lifestyle companies. Supreme Cannabis’ portfolio of brands caters to diverse consumer experiences, with brands and products that address recreational, wellness, medicinal and new consumer preferences. 

The Company’s brand portfolio includes:

  1. 7ACRES
  2. Blissco
  3. Truverra
  4. Sugarleaf by 7AC 
  5. Khalifa Kush Enterprises Canada

Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including, scaled cultivation, value-add processing, centralized manufacturing and product testing and R&D.

Follow the company on InstagramTwitterFacebook, LinkedIn and YouTube.

We simply grow better.

SOURCE The Supreme Cannabis Company, Inc.